Summary: You can get drug coverage two ways: a standalone Part D plan paired with Original Medicare, or a Medicare Advantage plan with built-in drug coverage (MA-PD). Advantage drug coverage often looks cheaper because the medical side subsidizes it, but the formularies are narrower and the networks tighter. This guide compares the two paths on cost, coverage, flexibility, and who each fits.
Roughly half of Medicare beneficiaries now get drug coverage through Medicare Advantage rather than standalone Part D. The choice is bundled with the larger Original Medicare versus Medicare Advantage decision, but the drug side has its own tradeoffs worth isolating.
This guide compares the drug coverage specifically, so you can weigh it alongside the medical-side differences.
There is one more structural difference worth knowing. Standalone Part D pairs naturally with Medigap, which covers Original Medicare's medical cost-sharing and is guaranteed renewable. Medicare Advantage has no Medigap equivalent: you cannot buy a supplement to cap an Advantage plan's out-of-pocket maximum.
This matters for the drug decision because heavy drug users are often heavy medical users too. A beneficiary with expensive prescriptions plus frequent specialist visits can face the Advantage plan's full medical out-of-pocket maximum alongside drug costs, while the Original-plus-Medigap-plus-Part-D path caps the medical side tightly. Price the whole household of risks, not just the pharmacy counter.
Standalone Part D pairs with Original Medicare (plus optionally Medigap): you buy a drug plan from one insurer, and it covers prescriptions nationwide at any pharmacy in its network. Medicare Advantage with drug coverage (MA-PD) bundles hospital, medical, and drug coverage in one plan from one insurer, usually an HMO or PPO with a defined provider network.
The drug benefit inside MA-PD follows the same 2026 rules: $615 maximum deductible, 25 percent coinsurance, $2,100 out-of-pocket cap. The benefit design is standardized; what differs is the formulary, the pharmacy network, and how the premium is subsidized.
MA-PD drug coverage often carries a lower incremental premium because the plan uses medical-side rebates to buy down the drug premium. CMS projected the average Part D portion of MA premiums at about $11.50 a month for 2026, versus about $34.50 for standalone plans. But the comparison that matters is total: MA-PD plus the Advantage plan's medical cost-sharing versus Original Medicare plus Medigap plus standalone Part D.
For the drug slice alone, MA-PD usually wins on premium and ties on the cap. Standalone wins on predictability: its costs do not depend on which Advantage plan you chose for medical care, and switching drug plans does not disturb your doctors.
Standalone Part D plans compete primarily on the drug benefit, so their formularies tend to be broader and their pharmacy networks wider. MA-PD formularies are serviceable but narrower on average, with more utilization management, because the plan's competitive energy goes into the medical side.
If you take specialty or unusual drugs, check the MA-PD formulary with extra care. A drug that is routine on a standalone plan's formulary may need prior authorization or step therapy on an MA-PD plan, and the appeals run through the Advantage plan's process.
Standalone Part D offers clean flexibility: change drug plans every open enrollment without touching your medical coverage, see any doctor who takes Medicare nationwide, and add Medigap for predictable medical costs. MA-PD bundles the decisions: changing drug coverage means changing your entire health plan, doctors and all.
The bundle cuts both ways. One card, one insurer, often lower total premiums, and extras like dental and vision that Original Medicare does not cover. Against that: networks, prior authorization on the medical side, and the annual re-shopping of the whole package.
Standalone Part D fits beneficiaries who value provider freedom, take complex or expensive drug regimens, travel or split time between states, or pair it with Medigap for maximum predictability. It is the choice for people who want the drug decision separable from everything else.
MA-PD fits beneficiaries comfortable with networks, in good health with simple drug regimens, prioritizing low premiums and bundled extras. It is the choice for people who want one plan and the lowest monthly outlay. Neither is universally better; the right answer follows your drugs, your doctors, and your travel.
Run both comparisons: price your drugs on two or three standalone plans and on the MA-PD plans available in your county, using the same pharmacy. Then layer the medical side: what would your expected medical cost-sharing be under each Advantage plan versus Original plus Medigap.
Decide on total expected cost plus a flexibility premium you assign yourself. If the totals are close, choose the structure you would rather live with when something goes wrong, because something eventually goes wrong.
Document the decision. Save the plan finder comparison or a screenshot of the totals you compared, with the date. Next October you will thank yourself: the comparison takes twenty minutes when last year's inputs are saved and over an hour when you start from scratch. Good records are what turn open enrollment from a chore into a habit.
It follows the same 2026 benefit rules ($615 deductible, 25%, $2,100 cap) but with the plan's own formulary, pharmacy network, and premium structure.
Standalone plans typically offer broader formularies and keep drug decisions separate from medical coverage. MA-PD often has lower incremental premiums. The better choice depends on your drugs and doctors.
Yes, during open enrollment (Oct 15-Dec 7). You would move to Original Medicare and add a standalone Part D plan; consider Medigap, noting medical underwriting may apply outside your initial enrollment period.
Yes. Everyone pays the Part B premium ($202.90 in 2026) regardless of path, plus any plan premium.
Figures: CMS 2026 parameters. Verify plan details in plan materials. This guide is for planning only.